Lipocine (LPCN) Prepaid Assets (2012 - 2025)
Lipocine's (LPCN) quarterly Prepaid Assets came in at $787600.0 in Q4 2025, up 38.68% YoY from $567915.0 in Q4 2024, and up 15.18% on a QoQ basis from $683797.0 in Q3 2025.
Lipocine (LPCN) Prepaid Assets (2012 - 2025) Analysis & Trends
Lipocine (LPCN) has 14 years of Prepaid Assets data on file, last reported at $787600.0 in Q4 2025.
- Quarterly Prepaid Assets rose 38.68% year-over-year to $787600.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $787600.0 (up 38.68% YoY) and the FY2025 annual result came in at $787600.0, up 38.68% from the prior year.
- Prepaid Assets climbed to $787600.0 in Q4 2025, from $683797.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.5 million in Q3 2021 to a low of $283180.0 in Q2 2021.
- A 5-year average of $772294.2 and a median of $643671.5 in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets soared 200.58% — and 2024, when it sank 57.01%.
- Tracing LPCN's Prepaid Assets over 5 years: stood at $1.5 million in 2021, then tumbled by 37.58% to $945319.0 in 2022, then retreated by 18.18% to $773424.0 in 2023, then decreased by 26.57% to $567915.0 in 2024, then jumped by 38.68% to $787600.0 in 2025.
- The last three Prepaid Assets figures came in at $787600.0 (Q4 2025), $683797.0 (Q3 2025), and $362629.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Lipocine | 11.15 Mn | -12.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 787,600.00 |
| Sep 30, 2025 | 683,797.00 |
| Jun 30, 2025 | 362,629.00 |
| Mar 31, 2025 | 428,795.00 |
| Dec 31, 2024 | 567,915.00 |
| Sep 30, 2024 | 588,824.00 |
| Jun 30, 2024 | 297,051.00 |
| Mar 31, 2024 | 583,087.00 |
| Dec 31, 2023 | 773,424.00 |
| Sep 30, 2023 | 594,097.00 |
| Jun 30, 2023 | 690,900.00 |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 945,319.00 |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 603,546.00 |
| Mar 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | 1.51 Mn |
| Sep 30, 2021 | 1.54 Mn |
| Jun 30, 2021 | 283,180.00 |
| Mar 31, 2021 | 458,423.00 |